Perbedaan Logindo Samudramakmur Tbk. dan Merck Tbk.: Logindo Samudramakmur Tbk. diperdagangkan di Rp101 (kapitalisasi pasar 574,16 M, volume 24 jam 12,07 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Logindo Samudramakmur Tbk., dan Logindo Samudramakmur Tbk. lebih aktif diperdagangkan (12,07 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LEAD | MERK | |
|---|---|---|
Kapitalisasi Pasar | 574,16 M | 1,7 T |
Volume | 12,07 jt | 37,6 rb |
Lot | 120,69 rb | 376 |
Perputaran | 1,2 M | 144,47 jt |
Harga Rata-rata | 99,77 | 3.842,23 |
Nilai Transaksi | 1,2 M | 144,47 jt |
Harga Ekuilibrium Indikatif | 101 | 3.840 |
Volume Ekuilibrium Indikatif | 3,23 rb | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Selengkapnya di halaman LEAD →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →